Willem J.S. de Villiers

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

William J. Sandborn, Christopher Gasink, Long-Long Gao et al. · New England Journal of Medicine · 2012 · 1.1K citations

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

William J. Sandborn, Paul Rutgeerts, Brian G. Feagan et al. · Gastroenterology · 2009 · 469 citations · Full text

Gastroenterology, Colectomy Rate Comparison, Visceral Surgery +5

Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial

William J. Sandborn, Rory Rebuck, Yuhua Wang et al. · Clinical Gastroenterology and Hepatology · 2021 · 229 citations · Full text

SR-BII, an Isoform of the Scavenger Receptor BI Containing an Alternate Cytoplasmic Tail, Mediates Lipid Transfer between High Density Lipoprotein and Cells

Nancy R. Webb, Patrice M. Connell, Gregory A. Graf et al. · Journal of Biological Chemistry · 1998 · 219 citations · Full text